Myofibroblasts are associated with the progression of scirrhous gastric carcinoma

Experimental and Therapeutic Medicine

Volumn 1, Issue 4, 2010, Pages 547-551

  Fuyuhiro, Yuhiko ^a   Yashiro, Masakazu ^a   Noda, Satoru ^a   Kashiwagi, Shinichiro ^a   Matsuoka, Junko ^a   Doi, Yosuke ^a   Kato, Yukihiro ^a   Muguruma, Kazuya ^a   Sawada, Tetsuji ^a   Hirakawa, Kosei ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Myofibroblasts; Scirrhous gastric carcinoma

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; VIMENTIN;

ADVANCED CANCER; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; DISEASE ASSOCIATION; FIBROBLAST; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MYOFIBROBLAST; PERITONEUM METASTASIS; PROGNOSIS; STOMACH CARCINOMA; STROMA CELL;

EID: 80855144042     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm_00000086     Document Type: Article

References (23)

1. Nakayama H, Enzan H, Miyazaki E and Toi M: Alpha smooth muscle actin-positive stromal cells in gastric carcinoma. J Clin Pathol 55: 741-744, 2002.
2. Ronnov-Jessen L, Petersen OW, Koteliansky VE and Bissell MJ: The origin of the myofibroblasts in breast cancer. recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. J clin Invest 95: 859-873, 1995.
3. Chauhan H, Abraham A, Phillips Jr, Pringle JH, Walker RA and Jones JL: There is more than one kind of myofibroblast: analysis of cD34 expression in benign, in situ, and invasive breast lesions. J clin Pathol 56: 271-276, 2003.
4. Tuxhorn JA, McAlhany SJ, Dang TD, Ayala ge and rowley Dr: Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DrS) xenograft model. Cancer Res 62: 3298-3307, 2002.
5. Albini A and Sporn MB: The tumour microenvironment as a target for chemoprevention. Nat rev cancer 7: 139-147, 2007.
6. Barth PJ and Westhoff CC: CD34+ fibrocytes: morphology, histogenesis and function. Curr Stem Cell Res Ther 2: 221-227, 2007.
7. Eyden B: The myofibroblast: a study of normal, reactive and neoplastic tissues, with an emphasis on ultrastructure. J Submicrosc cytol Pathol: 231-296, 2007.
8. Eyden B: The myofibroblast: phenotypic characterization as a prerequisite to understanding its functions in translational medicine. J cell Mol Med 12: 22-37, 2008.
9. Orimo A, Gupta PB, Sgroi DC, et al: Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/cXcl12 secretion. Cell 121: 335-348, 2005.
10. De Wever O, Demetter P, Mareel M and bracke M: Stromal myofibroblasts are drivers of invasive cancer growth. Int J cancer 123: 2229-2238, 2008.
11. Tahara E: growth factors and oncogenes in human gastrointestinal carcinomas. J Cancer Res Clin Oncol 116: 121-131, 1990.
12. Yashiro M, Chung YS and Sowa M: Role of orthotopic fibroblasts in the development of scirrhous gastric carcinoma. Jpn J Cancer Res 85: 883-886, 1994. 1998.
13. Japanese gastric cancer A: Japanese classification of gastric carcinoma 2nd english edition. Gastric Cancer 1: 10-24.
14. Maruyama M, Sasaki T and Kubota H: [endoscopic treatment of early cancer of the large bowel]. Gan No Rinsho 32: 1309-1316, 1986.
15. Orimo A, Tomioka Y, Shimizu Y, et al: Cancer-associated myofibroblasts possess various factors to promote endometrial tumor progression. Clin Cancer Res 7: 3097-3105, 2001.
16. Nakazawa K, Yashiro M and Hirakawa K: Keratinocyte growth factor produced by gastric fibroblasts specifically stimulates proliferation of cancer cells from scirrhous gastric carcinoma. Cancer Res 63: 8848-8852, 2003.
17. Inoue T, chung YS, Yashiro M, et al: Transforming growth factor-beta and hepatocyte growth factor produced by gastric fibroblasts stimulate the invasiveness of scirrhous gastric cancer cells. Jpn J Cancer Res 88: 152-159, 1997.
18. Tsujino T, Seshimo I, Yamamoto H, et al: Stromal myofibroblasts predict disease recurrence for colorectal cancer. Clin Cancer Res 13: 2082-2090, 2007.
19. Wipff PJ, Rifkin DB, Meister JJ and Hinz B: Myofibroblast contraction activates latent TgF-beta1 from the extracellular matrix. J cell biol 179: 1311-1323, 2007.
20. Ronnov-Jessen L and Petersen OW: Induction of alpha-smooth muscle actin by transforming growth factor-beta 1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia. Lab Invest 68: 696-707, 1993.
21. Saito H, Tsujitani S, Oka S, et al: The expression of transforming growth factor-beta1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma. Cancer 86: 1455-1462, 1999.
22. kinugasa S, Abe S, Tachibana M, et al: Overexpression of transforming growth factor-beta1 in scirrhous carcinoma of the stomach correlates with decreased survival. Oncology 55: 582-587, 1998.
23. Yoshida K, Yokozaki H, Niimoto M, Ito H, Ito M and Tahara E: expression of TgF-beta and procollagen type I and type III in human gastric carcinomas. Int J Cancer 44: 394-398, 1989.